The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of intellectual-property theft in China.
Peter Loftus is a reporter at The Wall Street Journal. He covers a range of topics within the healthcare sector, focusing on pharmaceuticals, medical devices, and the healthcare system, with particular attention to nutrition, the COVID-19 pandemic, and regulatory matters like the FDA. Peter's work has also been featured in MarketWatch, LiveMint, and Yahoo Finance.